AUPH:US
$8.025
-1.048%

Aurinia Pharmaceuticals Inc
Insider Activity

Last updated: May 9, 2025, 12:45 PM ET

Profile

Company Description

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

Sector

Healthcare

Industry

Biotechnology